Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry is added to the record history. The previous Revision: v3.6.6 is removed, updating the page’s version-history display to reflect the latest platform release.
    Difference
    0.1%
    Check dated 2026-09-20T19:56:15.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page's record history shows Revision: v3.6.6 instead of v3.6.5, indicating a software/UI revision in the history metadata. This change is metadata and does not alter trial data or the content of the study record.
    Difference
    0.1%
    Check dated 2026-08-30T15:17:55.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    New revision entry v3.6.5 was added to the record history, replacing v3.6.4. This reflects a minor update to the page's revision metadata rather than substantive study information.
    Difference
    0.1%
    Check dated 2026-08-09T08:41:20.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The record history now shows the latest revision, updating from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T16:55:30.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed. This reflects an update to the record's version in the history log.
    Difference
    0.1%
    Check dated 2026-07-04T04:43:38.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, indicating a platform update. There is no visible impact on the study history entries or data.
    Difference
    0.1%
    Check dated 2026-06-27T03:58:10.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.